Stockreport

Merck drug Keytruda succeeds in late-stage esophageal cancer trial [Reuters]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Merck drug Keytruda succeeds in late-stage esophageal cancer trial | Reuters 2 Min Read (Reuters) - Merck & Co’s blockbuster drug Keytruda met the main goal of a late-st [Read more]